Carisma Therapeutics, Inc.
CARM
$0.06
$0.019.62%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 45.25M | -- | 3.73M | 3.65M | 3.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.25M | -- | 3.73M | 3.65M | 3.39M |
| Cost of Revenue | 197.00K | 2.42M | 9.16M | 15.58M | 11.33M |
| Gross Profit | 45.05M | -2.42M | -5.43M | -11.93M | -7.94M |
| SG&A Expenses | 1.24M | 3.35M | 3.91M | 3.93M | 5.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.44M | 5.78M | 13.06M | 19.51M | 16.53M |
| Operating Income | 43.81M | -5.78M | -9.33M | -15.86M | -13.14M |
| Income Before Tax | 44.72M | -9.77M | -9.27M | -17.64M | -12.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.72M | -9.77M | -9.27M | -17.64M | -12.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.72M | -9.77M | -9.27M | -17.64M | -12.70M |
| EBIT | 43.81M | -5.78M | -9.33M | -15.86M | -13.14M |
| EBITDA | 43.81M | -5.78M | -8.67M | -15.19M | -12.41M |
| EPS Basic | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| Normalized Basic EPS | 0.66 | -0.08 | -0.14 | -0.23 | -0.19 |
| EPS Diluted | 1.07 | -0.23 | -0.22 | -0.42 | -0.31 |
| Normalized Diluted EPS | 0.66 | -0.08 | -0.14 | -0.23 | -0.19 |
| Average Basic Shares Outstanding | 41.79M | 41.79M | 41.77M | 41.75M | 41.59M |
| Average Diluted Shares Outstanding | 41.94M | 41.79M | 41.77M | 41.75M | 41.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |